LBS-PR-A Fundamental Analysis - LIFE & BANC SPLIT CORP - LBSCN 7 1/4 10/30/28

Fundamental Rating

Overall LBS-PR-A gets a fundamental rating of 3 out of 10. We evaluated LBS-PR-A against 0 industry peers in the Unkown industry. While LBS-PR-A seems to be doing ok healthwise, there are quite some concerns on its profitability. LBS-PR-A is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year LBS-PR-A was profitable.

LBS-PR-A had a negative operating cash flow in the past year.

The reported net income has been mixed in the past 5 years: LBS-PR-A reported negative net income in multiple years.

In the past 5 years LBS-PR-A reported 4 times negative operating cash flow.

1.2 Ratios

		Industry Rank	Sector Rank
ROA	17.67%
ROE	36.14%
ROIC	32.14%

ROA(3y)5.01%

ROA(5y)6.34%

ROE(3y)9.62%

ROE(5y)11.76%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

LBS-PR-A's Profit Margin has been stable in the last couple of years.

In the last couple of years the Operating Margin of LBS-PR-A has remained more or less at the same level.

LBS-PR-A's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	97.18%
PM (TTM)	78.66%
GM	97.38%

OM growth 3Y0.15%

OM growth 5Y0.39%

PM growth 3Y-3.24%

PM growth 5Y-0.69%

GM growth 3Y-0.07%

GM growth 5Y0.27%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

Compared to 1 year ago, LBS-PR-A has more shares outstanding

LBS-PR-A has more shares outstanding than it did 5 years ago.

LBS-PR-A has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

LBS-PR-A has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	N/A

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

LBS-PR-A has a Current Ratio of 1.96. This is a normal value and indicates that LBS-PR-A is financially healthy and should not expect problems in meeting its short term obligations.

LBS-PR-A has a Quick Ratio of 1.96. This is a normal value and indicates that LBS-PR-A is financially healthy and should not expect problems in meeting its short term obligations.

		Industry Rank	Sector Rank
Current Ratio	1.96
Quick Ratio	1.96

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 137.99% over the past year.

Measured over the past 5 years, LBS-PR-A shows a small growth in Earnings Per Share. The EPS has been growing by 3.27% on average per year.

LBS-PR-A shows a strong growth in Revenue. In the last year, the Revenue has grown by 128.05%.

LBS-PR-A shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.89% yearly.

EPS 1Y (TTM)137.99%

EPS 3Y-7.65%

EPS 5Y3.27%

EPS Q2Q%433.71%

Revenue 1Y (TTM)128.05%

Revenue growth 3Y9.21%

Revenue growth 5Y14.89%

Sales Q2Q%309.57%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 3.10, which indicates a rather cheap valuation of LBS-PR-A.

When comparing the Price/Earnings ratio of LBS-PR-A to the average of the S&P500 Index (27.45), we can say LBS-PR-A is valued rather cheaply.

		Industry Rank	Sector Rank
PE	3.1
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)0.95

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

LBS-PR-A has a Yearly Dividend Yield of 4.93%, which is a nice return.

LBS-PR-A's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.

		Industry Rank	Sector Rank
Dividend Yield	4.93%

5.2 History

The dividend of LBS-PR-A decreases each year by -0.03%.

LBS-PR-A has paid a dividend for at least 10 years, which is a reliable track record.

LBS-PR-A has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.

Dividend Growth(5Y)-0.03%

Div Incr Years2

Div Non Decr Years10

5.3 Sustainability

32.11% of the earnings are spent on dividend by LBS-PR-A. This is a low number and sustainable payout ratio.

DP32.11%

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

LIFE & BANC SPLIT CORP - LBSCN 7 1/4 10/30/28

TSX:LBS-PR-A (7/3/2025, 7:00:00 PM)

10.98

+0.02 (+0.18%)

Chartmill FA Rating

GICS SectorN/A

GICS IndustryGroupN/A

GICS IndustryN/A

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners0.01%

Ins Owner ChangeN/A

Market Cap515.29M

Analysts0

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	4.93%

Yearly Dividend1.21

Dividend Growth(5Y)-0.03%

DP32.11%

Div Incr Years2

Div Non Decr Years10

Ex-Date03-31 2025-03-31 (0.18125)

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	3.1
Fwd PE	N/A
P/S	2.45
P/FCF	N/A
P/OCF	N/A
P/B	1.13
P/tB	1.13
EV/EBITDA	N/A

EPS(TTM)3.54

EY32.24%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.73

FCFYN/A

OCF(TTM)-0.73

OCFYN/A

SpS4.48

BVpS9.75

TBVpS9.75

PEG (NY)N/A

PEG (5Y)0.95

Profitability

		Industry Rank	Sector Rank
ROA	17.67%
ROE	36.14%
ROCE	44.65%
ROIC	32.14%
ROICexc	N/A
ROICexgc	N/A
OM	97.18%
PM (TTM)	78.66%
GM	97.38%
FCFM	N/A

ROA(3y)5.01%

ROA(5y)6.34%

ROE(3y)9.62%

ROE(5y)11.76%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3Y0.15%

OM growth 5Y0.39%

PM growth 3Y-3.24%

PM growth 5Y-0.69%

GM growth 3Y-0.07%

GM growth 5Y0.27%

F-Score6

Asset Turnover0.22

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	145923
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.96
Quick Ratio	1.96
Altman-Z	N/A

F-Score6

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)137.99%

EPS 3Y-7.65%

EPS 5Y3.27%

EPS Q2Q%433.71%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)128.05%

Revenue growth 3Y9.21%

Revenue growth 5Y14.89%

Sales Q2Q%309.57%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y151.44%

EBIT growth 3Y9.36%

EBIT growth 5Y15.34%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y43.04%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y43.04%

OCF growth 3YN/A

OCF growth 5YN/A

LIFE & BANC SPLIT CORP - LBSCN 7 1/4 10/30/28 (LBS-PR-A.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens